23 days ago
HRMY
AnalystsDavid HoangDavid Hoang's Stock Forecasts
AnalystsDavid Hoang
Sectors:
Analyst Ranking
Top 23%
#1138 out of 4955 analysts
Average Return
+5.37%
Win Rate
50%17 out of 34
Risk vs Reward
Poor
Good
David Hoang's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +181.99% | $21.27 | $59.98 | 2024-02-15 - 2024-11-29 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +95.12% | $30.74 | $59.98 | 2024-07-01 - 2024-11-29 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +82.59% | $32.85 | $59.98 | 2024-08-01 - 2024-11-29 | Strong Buy |
Sarepta Therapeutics IncSRPT | +70.35% | $92.11 | $156.91 | 2023-12-12 - 2024-06-26 | Strong Buy |
Axsome Therapeutics IncAXSM | +56.88% | $76.72 | $120.36 | 2024-03-25 - 2025-03-25 | Strong Buy |
David Hoang Analyst Color
Get additional color on David Hoang's coverage of popular stocks
4 months ago
ALKS
a year ago
SRPT
David Hoang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Harmony Biosciences Holdings IncHRMY | 3 | Strong Buy | $55.00 | +59.88% | Maintains | 23 days ago |
Sarepta Therapeutics IncSRPT | 7 | Hold | $25.00 | +57.13% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $35.00 | +48.75% | Upgrades | 2 months ago |
Alkermes PLCALKS | 2 | Strong Buy | $52.00 | +95.86% | Maintains | 4 months ago |
Xenon Pharmaceuticals IncXENE | 3 | Strong Buy | $67.00 | +119.67% | Initiates Coverage On | 6 months ago |
Praxis Precision Medicines IncPRAX | 1 | Strong Buy | $111.00 | +105.21% | Initiates Coverage On | 6 months ago |
Denali Therapeutics IncDNLI | 3 | Strong Buy | $31.00 | +130.65% | Initiates Coverage On | 6 months ago |
Biohaven LtdBHVN | 1 | Strong Buy | $65.00 | +341.88% | Initiates Coverage On | 6 months ago |
Axsome Therapeutics IncAXSM | 4 | Strong Buy | $176.00 | +70.84% | Initiates Coverage On | 6 months ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Strong Buy | $12.00 | +8.30% | Initiates Coverage On | 6 months ago |
Neurocrine Biosciences IncNBIX | 4 | Hold | $158.00 | +22.57% | Maintains | a year ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $50.00 | -16.64% | Maintains | a year ago |
Acumen Pharmaceuticals IncABOS | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | a year ago |
Sage Therapeutics IncSAGE | 1 | Strong Sell | $8.00 | N/A | Initiates Coverage On | a year ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | $220.00 | N/A | Initiates Coverage On | 2 years ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Buy | $80.00 | N/A | Initiates Coverage On | 2 years ago |
Provention Bio IncPRVB | 1 | Hold | $25.00 | N/A | Downgrades | 2 years ago |
Gossamer Bio IncGOSS | 1 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Orchard Therapeutics PLCORTX | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.